Date	Period	Revenue/Estimate	Earnings Call
--	2025/H1	-- / 151.494B	--
--	2024/H2	-- / 142.721B	--
Aug 29, 2024	2024/H1	141.282B / --	--
Mar 26, 2024	2023/H2	114.635B / 136.356B	--
Aug 31, 2023	2023/H1	138.940B / 137.924B	--

DatePeriodRevenue/EstimateEarnings Call

--2025/H1-- / 151.494B--

--2024/H2-- / 142.721B--

Aug 29, 20242024/H1141.282B / ----

Mar 26, 20242023/H2114.635B / 136.356B--

Aug 31, 20232023/H1138.940B / 137.924B--

Unlock Free Earnings Estimates

Open Account

CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFDONG-E-E-JIAO FOR THE NINE MONTHS ENDED30 SEPTEMBER 2024

Oct 30 08:23 ET

CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFCR SANJIU FOR THE NINE MONTHS ENDED30 SEPTEMBER 2024

Oct 25 08:50 ET

CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFJIANGZHONG PHARMACEUTICALFOR THE NINE MONTHS ENDED 30 SEPTEMBER 2024

Oct 25 07:49 ET

CHINARES PHARMA: ANNOUNCEMENTUNAUDITED FINANCIAL RESULTS OFKPC FOR THE NINE MONTHS ENDED30 SEPTEMBER 2024

Oct 25 07:04 ET

Updated: Dec 16, 2024

Strong Buy

No Data

Overall

No Data

03320 CHINARES PHARMA

CHINARES PHARMA Key Stats